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SUMMARY
Bone morphogenetic protein 2 (BMP2) is one of the most important cytokines in this regard, and plays several important roles in a variety of cellular functions ranging from embryogenesis, cell growth, and differentiation to bone development and the repair of bone fractures [1, 2] . Recently, another BMP2 signaling pathway in osteoblasts, mediated by the unfolded protein response (UPR) of endoplasmic reticulum(ER) stress, was introduced by Murakami et al [3] . The expression levels of the ER stress markers, IgH chain binding protein (BiP), C/EBP homologous protein (CHOP), activating transcription factor 4 (ATF4), and ER degradation enhancing α-mannosidase-like protein (EDEM), were up-regulated by BMP2 stimulation. Jang WG [4] reported that BMP2 activates unfolded protein response (UPR) transducers, such as PERK,OASIS and ATF6.BMP2 stimulated ATF6 transcription by enhancing the direct binding of Runx2 to the osteoblast-specific cis-acting element 2 (OSE2) motif of the ATF6 promoter region.
The unfolded protein response is mediated by a multifaceted intracellular signaling pathway triggered by inhibition of glycosylation, Ca 2+ depletion, and other stress conditions that interfere with protein folding in the endoplasmic reticulum (ER) [5, 6] .The UPR consists of three molecular branches (inositol requiring enzyme 1, IRE1; PKR-like ER resistant kinase, PERK and activating transcription factor 6, ATF6), which promote cell survival by reducing misfolded protein levels. Accumulated evidences indicate a physiological role of UPR during developmental processes. Extensive studies have elucidated the relationship between UPR and plasma cell differentiation. IRE1α mouse embryos display diminished growth rate, prominent apoptosis in hepatocytes and embryonic lethality [7, 8] .
Human X-box binding protein 1 (XBP1) is a signaling molecule downstream of IRE1 in the IRE1-XBP1 pathway of the UPR, and participates in IRE1α-mediated UPR signal transmission. XBP1 also helps to coordinate IRE1α-dependent XBP1 mRNA splicing [9] [10] [11] . XBP1 exists in two forms: XBP1 spliced (XBP1S) or XBP1 unspliced (XBP1U) isoforms. In mammalian cells, IRE1 is activated by ER stress and subsequently processes XBP1 mRNA to generate the spliced form of XBP1 protein (XBP1S). Although there is some evidence that XBP1 plays an important role in the control of cell proliferation and the differentiation of numerous types of cells and tissues including adipogenesis, myelomapathogenesis, skeletal muscle myotubes, dendritic cells in ER stress [12] [13] [14] [15] , little is known about the modulation and physiological significance of XBP1S in chondrogenesis. Specifically, the molecular mechanism by which XBP1S regulates chondrogenesis also remains unknown. In our present study, we attempt to elucidate the role of transcriptional factor XBP1S in chondrogenesis; with the special focus on associated molecules of hypertrophic chondrocyte differentiation, and its molecular events underlying this process.
EXPERIMENTAL PROCEDURES
Plasmids and Adenoviruses-To generate wild-type and two mutants of the pGL3-XBP1-luc reporter plasmid, the corresponding segments were amplified using PCR with the following primers: 5'-GTCACGCGACGCTGGCCAATCGCGGAG GGCCACGAC-3' and 5'-GTCGTGGCCCT CCGCGATTGGCCAGCGTCGCGTGAC-3' for wild-type XBP1-luc; 5'-gtcacgcgacgctgg attatcgcggagggccacgac-3' and 5'-gtcgtggccctc cgcgataatccagcgtcgcgtgac-3' for mut 1; 5'-gccaatcgcggagggctgataccgtagaaaggccg -3' and 5'-cggcctttctacggtatcagccctccgcgattggc -3'for mut 2 (the mutated nucleotides in the primers are underlined). PCR products were inserted into the pGL3 vector.
To generate XBP1S siRNA expression constructs, siRNA corresponding to the coding sequence of XBP1S gene (5'-ATGCCAATGAACTCTTTCCCTTTT-3') was cloned into a pSES-HUS vector (an adenoviral shuttle vector expressing siRNA) according to the manufacturer's instructions. Briefly, equimolar amounts of complementary sense and antisense strands were separately mixed, annealed and slowly cooled to 10℃ in a 50-μl reaction buffer (100mM NaCl and 50mM HEPES, pH 7.4). The annealed oligonucleotides were inserted into the SfiI sites of pSES-HUS vector. All constructs were verified by nucleic acid sequencing; subsequent analysis was performed using BLAST software (available at http://www. ncbi.nlm.nih.gov/blast/).
Adenovirus(Ad) XBP1S siRNA, AdATF6 siRNA, and Adenovirus encoding XBP1S, ATF6, IRE1a, Runx2 were constructed respectively using methods described previously [16, 17, 44] .
Isolation and Culture of Mouse Bone
Marrow Stromal Cells (BMSCs) -Mouse bone marrow was isolated by flushing the femurs and tibiae of 8-to 12-wk-old female BALB/c mice with 0.6 ml of improved minimal essential medium (IMEM; Sigma-Aldrich, St. Louis, MO), supplemented with 20% fetal bovine serum, 100U/ml penicillin/100μg/ml streptomycin (Invitrogen), and 2 mM glutamine (Invitrogen), and then it was filtered through a cell strainer (Falcon; BD Biosciences Discovery Labware, Bedford, MA). Cells were centrifuged for 10 min at 260 × g, washed by the addition of fresh medium, centrifuged again, resuspended, and plated out in IMEM supplemented with 20% fetal bovine serum (FBS), 100 U/ml penicillin/100μg/ml streptomycin, and 2 mM glutamine at a density of ~2×10 Assays-on-Demand Gene Expression Products. We select GAPDH as the endogenous control for the real-time PCR relative quantification analysis. PCR cycling conditions were as follows: initial incubation step of 2 min at 50℃, reverse transcription of 60 min at 60℃ and 94℃ for 2 min, followed by 40 cycles of 15 s at 95℃ for denaturation and 2 min at 62 ℃ for annealing and extension.
In the case of Collagen Ⅱ, Collagen X, Runx2, IHH and PTHrP, realtime PCR was run using the SYBR GREEN PCR kit and the following primers were used: sense 3'-AACGAGAACGACGAGGTGGT-5',antis ense 3'-AAAGGAGGCAGATGACAGGTG AC-5'(Collagen II);sense 3'-TACCACGTG CATGTGAAAGG -5' , antisense 3'-GGA GCCACTAGGAATCCTGAG -5' (Collagen X); sense 3'-TCAAACGCCTCTTCAGCGC AGTG-5', antisense 3'-GGCTGGTGCTCG GATCCCAAAAGA-5' (Runx2); sense 3'-GA GTCCCCAAGAGCCACCCA-5',antisense 3' -TGGTGGGCTGATAGGTGGGC-5' (IHH); sense 3'-ATGCTGCGGAGGCTGGTTCA-5' , antisense 3'-GCACGGAGTAGCTGAG CAGGA A-5' (PTHrP).
Immunoblotting analysis -To examine the expression of XBP1S and Collagen X protein in the course of chondrogenesis, total cell extracts prepared from micromass cultures of C3H10T1/2 cells in the presence of 300 ng/ml recombinant BMP2 protein were mixed with 5 × sample buffer (312.5mM Tris-HCl (pH 6.8), 5% b-mercaptoethanol, 10% SDS, 0.5% bromophenol blue, 50% glycerol). Proteins were resolved on a 10% SDS-polyacrylamide gel and electroblotted onto a nitrocellulose membrane. After blocking in 10% nonfat dry milk in Tris buffer saline Tween 20 (10mM Tris-HCl (pH 8.0), 150mM NaCl, 0.5% Tween 20), blots were incubated with either mouse monoclonal anti-XBP1S antibody (BioLegend, diluted 1:500) or rabbit polyclonal anti-Collagen X (Santa Cruz Biotechnology, 1: 500) for 1 h. After washing, the respective secondary antibody (HRP-conjugated anti-mouse immunoglobulin or HRP-conjugated anti-rabbit immunoglobulin, Sigma, both 1:1000 dilution) was added, and bound antibody was visualized using an enhanced chemiluminescence system (Amersham Biosciences).
RT-PCR -Total RNA was isolated from 300 ng/ml BMP2-treated micromass cultures of C3H10T1/2 cells with the RNeasy mini kit (Qiagen, Alameda, CA, USA) and then reverse-transcribed to cDNA as described in the protocol of the Improm-II Reverse Transcriptase system kit (Promega, Madison, WI, USA). The following sequence-specific primers were synthesized: 5'-ATGGTGGTG GTGGCAGCCGC-3' and 5'-GACACTAAT CAGCTGGGGAAAGAG-3' for XBP1S ; 5'-TACCACGTGCATG TGAAAGG -3' and 5'-GGAGCCACTAGGAATCCTGAG -3' for Collagen X. The following pair of oligonucleotides was used as internal controls: 5'-ACCACAGTCCATGCCATCAC-3' and 5'-TCCACCACCCTGTTGCTGTA-3' for GAPDH. PCRs were performed for 35 cycles (94℃ 1 min, 60℃ 1 min and 72℃ 1 min) with a final elongation for 10 min at 72℃. GAPDH was also amplified and employed as an internal control for 35 cycles (94℃ 1 min, 55℃ 1 min and 72℃ 1 min). The PCR product was analyzed by 1% agarose gel electrophoresis.
Electrophoretic mobility shift assays -
The ATDC5 cells were seeded at 5 × 10 6 cells/well of a six-well plate in media containing 10% FBS. The cells were cultured overnight and transfected the following day with pcDNA3.1(-)-ATF6 (3μg) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. After 48 h, the cells were scraped from the plate by cold PBS, transferred to 10-ml tubes and centrifuged 10 min at 4,000 rpm. The cell pellet was resuspended in 400μl cold buffer (10 mM HEPES [pH 7.9], 1 mM DTT,10 mM KCl, 0.5 mM PMSF, 0.1 mM EDTA, 0.1 mM EGTA and 19 protease inhibitors [Roche]) by gentle pipetting and placed on ice for 15 min. We then added 25 μl 10% NP-40, vortexed vigorously for 10 s, centrifuged at 14,000 rpm for 1 min, aspirated the supernatant and kept the pellet. We resuspended the nuclear pellet in a 50-ml ice-cold buffer (20 mM HEPES [pH 7.9], 1 mM DTT, 0.4 mM NaCl, 1 mM PMSF, 1 mM EDTA, 1 mM EGTA and 19 protease min, inhibitors [Roche] ) and rocked the tube for 30 min at 4 ℃ . It was then centrifuged for 15 min; 14,000 rpm at 4 ℃ .Double-stranded oligonucl-eotides containing a specific ATF6-binding sequence located within the 5'-flanking region of XBP1 gene (5'-CCAATCGCGGAGGGC CACG -3') [19] were synthesized. The probes were labeled with digoxigenin (DIG)-11-ddUTP, and EMSAs were performed using a DIG gel shift kit (Roche Applied Science). Competition experiments were performed by preincubating nuclear extract with excess unlabeled probes before adding labeled oligonucleotides. In supershift assays, 5 ug of anti-ATF6 antibody (Santa Cruz Biotechnology) were incubated with the reaction mixture for 15 min before the addition of the digoxigenin-labeled probe. Reaction mixtures were incubated for 20 min at room temperature. Samples were subjected to electrophoresis on a native 5% polyacrylamide gel run in 0.5 × TBE (89 mmol/l Tris-HCl, 89 mmol/l boric acid and 2 mmol/l EDTA) for 2.5 h at 100 V. The signal was detected using a chemiluminescent detection system (Roche Applied Science).The method was described as previously [18, 36] .
Chromatin immunoprecipitation -C3H10T1/2 cells transfected with pcDNA3.1(-)-ATF6 plasmid, or treated with BMP2, were fixed by 1% formaldehyde for 10 min before cell lysis. Cell lysates were subsequently sonicated, followed by centrifugation. The input (1% of the supernatant) was used in PCR as a positive control. The supernatant was then precleared using protein A agarose/salmon sperm DNA for 30 min at 4℃. After centrifugation, the supernatant was then used for immunoprecipitation using anti-ATF6 antibody or control IgG and incubated overnight at 4℃. The protein/DNA complex was subsequently incubated with protein A agarose/salmon sperm DNA for 1 h at 4℃. The immune complex was collected by centrifugation and then washed five times with the following for 5 min each: once with low-salt immune complex wash buffer, once with high-salt immune complex wash buffer, once with LiCl salt immune complex wash buffer and twice with TE buffer. Histone/DNA complex was eluted from the antibody using elution buffer (1% SDS, 0.1M NaHCO3) and added 5M NaCl to reverse histone-DNA crosslink by heating for 4 h at 65 ℃ . The DNA was then extracted with phenol-chloroform and precipitated with ethanol in the presence of glycogen (20 mg) as a carrier. The precipitate was used as a template for PCR amplification. The primers specifically amplified two 120-bp segments spanning ATF6-binding site of the XBP1 gene promoter. The sequences of primers are following: sense 5'-CAATGGACGCCGAGC TCG -3' and antisense 5'-CATAGCTCCAG ACTACGC-3'. PCR was performed under the following conditions: 94℃ 5 min, 35 cycles at 94℃ for 30 s, 56℃ for 30 s and 72℃ for 45 s.
Reporter gene assays -C3H10T1/2 and ATDC5 cells were plated at a density of 3× 10 5 cells per well in six-well tissue culture plates and transfected with XBP1-specific reporter plasmids [ pGL3-XBP1-luc, pGL3-XBP1(mut1)-luc or pGL3-XBP1(mut2)-luc ], pcDNA3.1( -) -ATF6 and pCMV-gal (an internal control for transfection efficiency). 48 hours after transfection, cells were harvested, and luciferase and β-galactosidase activity was measured using the Bioscan Minilum. Relative transcriptional activity was expressed as a ratio of luciferase reporter gene activity from the experimental vector to that from the internal control vector. The cultures were processed and analyzed as described above.
Coimmunoprecipitation -Approximately 500 mg of cell extract proteins prepared from ATDC5 cells cotransfected with Runx2 and XBP1S expression plasmids [ pcDNA3.1(-)-XBP1S and pcDNA3.1( -)-Runx2 ] or BMP2-treated micromass culture of ATDC5 cells were incubated with anti-Runx2 (Santa Cruz Biotechnology,20 mg/ml) or control rabbit IgG (25 mg/ml) antibodies for 1 h, followed by incubation with 30 ml of protein A-agarose (PerkinElmer Life Sciences) at 4℃ overnight. After washing five times with immunoprecipitation buffer, bound proteins were released by boiling in 20 ml of 2×SDS loading buffer for 3 min. Released proteins were examined by western blotting with anti-XBP1S antibody, and the signal was detected using the ECL chemiluminescent system.
Statistical test -The statistical analysis was performed with SPSS 10.0.1 software for Windows. Data were expressed as mean ± SD from at least three independent experiments. Data for multiple variable comparisons were analyzed by one-way analysis of variance (ANOVA). P values ＜ 0.05 were deemed statistically significant.
RESULTS
Differential expression of XBP1S in the course of chondrogenesis-It is reported that ER stress signal molecules were associated with chondrogenesis [20] [21] [22] [23] . In this study, we sought to determine whether XBP1S, an important transcription factor in ER stress, was also involved in the chondrocyte differentiation. We first studied XBP1S expression profiles during chondrocyte differentiation using the C3H10T1/2 cell line; a pluripotent murine stem cell line that is widely used for in vitro chondrogenic studies [24] [25] [26] . Micromass cultures of these cells were incubated in the presence of 300 ng/ml recombinant bone morphogenetic protein 2(BMP2) for induction of chondrocyte differentiation. Cells were harvested at various time points followed by real-time PCR for measurements of XBP1S, collagen X, collagenⅡand Aggrecan (Fig.1A) . As shown in Fig. 1A , the level of XBP1S was relatively low until day 5, when it has doubled and thereafter remained at high levels during the differential stage. While collagen Ⅱ and Aggrecan were declined after BMP2-treated 5 days. Note that the peak level of XBP1S was 2 d earlier than that of collagen X, a specific marker for hypertrophic chondrocytes, suggesting that XBP1S may regulate collagen X expression. In addition, similar results were also observed in the course of chondrogenesis of primary bone marrow stromal cells (BMSCs, Fig. 1B ).
Then we examined the expression profile of XBP1S during chondrocyte differentiation in micromass culture of the pluripotent ATDC5 cell line, a well-established in vitro cell model. As revealed in Fig 1C, XBP1S protein was not detected until day 5 in BMP2-induced chondrocyte differentiation of ATDC5 cells, and Collagen X was also immunopositive at day 7, indicating that XBP1S expression is prehypertrophic and hypertrophic chondrocyte specific. More significantly, XBP1S expression was 2 d earlier than that of Collagen X, and similar results were also observed in the chondrogenesis of BMSCs (Fig.1D) .
Expression of XBP1S in growth plate chondrocytes in vivo-
To deeply investigate XBP1S function in chondrogenesis, we then examined the expression of XBP1S in growth plate chondrocytes using immunohistochemistry on tibial growth plates of mouse embryos on postcoital day 15.5, 18.5 and newborn. As revealed in Fig. 2, XBP1S is detected at E15.5, E18.5 and in the newborn respectively. The results demonstrate that XBP1S prominent expression throughout the growth plate chondrocytes is detected at E15.5, E18.5 and in the newborn. These results suggested that the expression profile of XBP1S is closely linked to the entire chondrogenesis, especially hypertrophic chondrocyte stage.
ATF6 binds to the promoter of the XBP1 gene both in vitro and in vivo-Next we sought to elucidate the role of XBP1S in chondrogenesis. In our initial sequence analysis of the human XBP1 gene promoter, we found an ERSE at −97 bp of the hXBP1 5′-flanking region [19, 20] . The sequence analysis revealed that ERSE is one of the ATF6-binding sites in the promoter of the XBP1 gene. These findings promoted us to examine whether ATF6 associates with the ERSE in the hXBP1 promoter in vitro and in vivo. For this purpose, we first examined whether ATF6 was able to bind to the XBP1 promoter in an electrophoretic mobility shift assay (EMSA) (Fig. 3A) .We incubated a digoxigenin-labeled probe corresponding to the ATF6 binding site with the nuclear extracts prepared from ATDC5 cells transfected with the mammalian expression plasmid pcDNA3.1(−)-ATF6, which resulted in a specific ATF6/DNA complex (Fig.3A,  lane 3) . Following the addition of anti-ATF6 antibodies , the antibody-ATF6-ERSE band was found to be supershifted (Fig. 3A, lane 4) . The binding of corresponding probes to ATF6 in vitro was completely competed by excess unlabeled probes (Fig.3A, lane 2) , indicating that the binding of ATF6 to their corresponding binding motifs is sequence-specific.
To determine whether ATF6 also binds to the XBP1 promoter in vivo, we next performed chromatin immunoprecipitation (ChIP) assays, which allow us to define interactions between protein factors and specific DNA elements in living cells. ChIP was carried out in C3H10T1/2 cells transfected with the mammalian expression plasmid pcDNA3.1(−)-ATF6. After crosslinking with formaldehyde, cell lysates were immunoprecipitated with either control IgG (negative control) or anti-ATF6 antibodies, and the DNA purified from this immunoprecipitation was analyzed by PCR with PCR primers that spanned the ATF6-binding site. We observed a clear PCR product using DNA isolated from immunoprecipitated complexes with anti-ATF6 but not with control IgG (Fig. 3B) Fig 3C showed that ATF6 can specifically bind to the promoter of XBP1 in the course of chondrogenesis.
ATF6 increases the transactivation of the XBP1 gene in the chondrocyte
pGL3-XBP1(-1311) and pGL3-XBP1(-407), were used in which segments containing ABEs (ATF6-binding elements) sequence from the 5'-flanking region of XBP1 (-1311 to +133, -407 to +133) were placed upstream of a gene encoding luciferase in the pGL3 vector (Fig. 4A, B) . The ERSE consensus sequence is 5'-CCAAT-N9-CCACG/A-3'. It was reported that ATF6 binds DNA on the 5'-CCACG/A-3' half of the ER stress response element (ERSE). Binding to ERSE requires binding of NF-Y to ERSE, and soluble ATF6 binds directly to CCACG/A only when CCAAT, exactly 9 bp upstream of CCACG, is bound to NF-Y [56, 57 ] .
We transfected both C3H10T1/2 stem cells and ATDC5 cells with these two reporter constructs together with expression plasmid pcDNA3.1(−)-ATF6. As shown in Fig 4C, D , ATF6 activated both pXBP1-specific reporter constructs in both cell lines, and the transactivations were dose-dependent.
As ATF6 is known to activate the expression of various genes, including other transcription factor(s) in chondrocytes and osteoblasts, the activation of the XBP1 gene by ATF6 observed above (Fig. 4C, D) might be due to the ATF6-activable transcription factor(s). To determine whether the increase in the expression of pGL3-XBP1 reporter genes in C3H10T1/2 cells and ATDC5 cells was directly dependent on the ATF6-specific sequences, the ATF6-specific binding element in pGL3-XBP1 was altered by replacing nucleotides from the sequence (Fig. 4E) . The replacement of the first five CCAAT with ATTAT or the second five nucleotides CCACG with CTGAT resulted in a strong decrease in the responsiveness to ATF6 of the expression of the reporter (Fig. 4F) . These data suggested that the ATF6-dependent increase in the expression of the reporter genes depends on direct association of ATF6 and XBP1 gene promoter.
ATF6 enhances the expression of XBP1S
in chondrogenesis -Firstly, we determined that ATF6 activates transcription of the XBP1 promoter using reporter gene assays. To further investigate whether this is also true for the endogenous XBP1S gene expression, we next did real-time PCR assay and western blotting with ATDC5 cells induced by BMP2(300 ng/ml). As shown in Fig 5A, we transfected ATDC5 cells with the XBP1 promoter core sequence reporter construct pGL3-XBP1 together with an ATF6 expression plasmid. ATF6 activated pGL3-XBP1 core sequence reporter constructs in ATDC5 cell lines, and the transactivations were dose-dependent. To further investigate whether this is also true for the endogenous XBP1S gene expression, we next did real-time PCR assay and western blotting with ATDC5 cells. As revealed in Fig 5B, 48 h after infection, ATF6 remarkably increased the XBP1S mRNA level (approximately three-to four fold increase).These results were also verified by western blotting at protein level, as shown in Fig.5C . It is apparent that after infection with Ad-ATF6 in ATDC5 cells induced by BMP2, XBP1S expression was enhanced and inhibition of ATF6 via Ad-ATF6 siRNA can reduce XBP1S expression in ATDC5 cells induced by BMP2. These data clearly indicated that ATF6 is required for XBP1 expression induced by BMP2, and ATF6 is able to regulate endogenous XBP1S gene expression. Micromass cultures of these cells were incubated in the presence of 300 ng/ml BMP2 for induction of chondrocyte differentiation and were infected with control Ad-GFP, Ad-ATF6 and Ad-IRE1a. As revealed in Fig  5D, 48 h after infection, IRE1a remarkably increased the XBP1S gene mRNA (approximately two-to three fold increase), and infection of ATF6 led to an approximately 50% enhancement in the level of XBP1S spliced by IRE1a. These results were also verified by western blotting at protein level. IRE1a obviously increased the XBP1S expression, and inhibition of IRE1a via siRNA approach can reduce XBP1S expression in chondrocytes. Besides, ATF6 can enhance the expression of IRE1a-spliced XBP1S in chondrogenesis. (Fig. 5E ).These data clearly indicated that IRE1a and ATF6 are able to regulate endogenous XBP1S gene expression in chondrogenesis. This expression is probably due to the activation of XBP1 gene by ATF6 and spliced by IRE1a.
Overexpressing

XBP1S enhances hypertrophic chondrocyte differentiation -
We next sought to determine the role of XBP1S in chondrocyte hypertrophy, we examined the effect of overexpression of XBP1S on chondrogenesis in micromass cultures of C3H10T1/2 and prechondrogenic ATDC5 cells. C3H10T1/2 or ATDC5 cells were infected with adenovirus encoding XBP1S (Ad-XBP1S) or control GFP (Ad-GFP), and overexpression of XBP1S was revealed in Fig 6A . Both cultures infected with Ad-XBP1S or control adenovirus were cultured in the presence of BMP2(300 ng/ml), and RNA was extracted every other day for real-time PCR. Chondrocyte differentiation was revealed by examining the expression of CollagenⅡ, Collagen X and Runx2, three marker genes widely used for chondrocyte maturation and hypertrophy. As shown in Fig.  6B Fig. 7 , knockdown of XBP1S completely abolished the CollagenⅡ (Fig.7 B,F) , and Collagen X (Fig.7 C,G) induction during chondrocyte differentiation.
In addition, induced expression of Runx2 in the course of chondrocyte differentiation was also largely blocked by knockdown of XBP1S ( Fig.7D and H). These findings clearly indicated that endogenous XBP1S is required for chondrocyte hypertrophy.
XBP1S associated with Runx2 in the
course of chondrocyte differentiation -We next sought to elucidate the molecular mechanism by which XBP1S mediates chondrocyte hypertrophy by determining whether XBP1S also associates with Runx2 in ATDC5 cells and in chondrocyte hypertrophy. To test whether XBP1S binds to Runx2 in ATDC5 cells, we cotransfected XBP1S and Runx2 expression plasmids into ATDC5 cells and performed a coimmunoprecipitation (Co-IP) assay. Briefly, extracts from ATDC5 cells, 48 h after transfection, were first incubated with control IgG (negative control) or anti-Runx2 antibodies, and the immunoprecipitated complexes were detected by western blotting with anti-XBP1S antibody. A XBP1S-specific band was present in the immunoprecipitated complexes brought down by anti-Runx2 (Fig. 8A, lane 2) , but not by control antibodies, demonstrating that XBP1S specifically associates with Runx2 in the transfected ATDC5 cells.
To examine whether XBP1S binds to Runx2 in chondrocyte differentiation, micromass culture of ATDC5 cells treated with BMP2 for 5 or 7 days were harvested respectively and a Co-IP assay was performed. Firstly, extracts from ATDC5 cells treated with BMP2 for 5 days were incubated with control IgG (Fig. 8B(a), lane 3) or anti-Runx2 antibodies (Fig. 8B(a), lane 2) , and the immunoprecipitated complexes were detected by western blotting with anti-XBP1S antibody. The result showed that XBP1S can not bind to Runx2 in ATDC5 cells treated with BMP2 for 5 days. Then extracts from ATDC5 cells treated with BMP2 for 7 days were incubated with control IgG (Fig. 8B(b), lane 3) or anti-Runx2 antibodies (Fig. 8B(b) , lane 2), and the immunoprecipitated complexes were detected by western blotting with anti-XBP1S antibody. As shown in Fig.8B , anti-Runx2 antibody efficiently brought down XBP1S protein, whereas control antibody could not, indicating that XBP1S and Runx2 form a protein complex in ATDC5 cells treated with BMP2 for 7 days. It is worth noting that the anti-XBP1S antibody also clearly brought down Runx2 protein in ATDC5 cells treated with BMP2 for 7 days, whereas the control antibody could not. Interestingly, a faint Runx2 band was visualized in the immunoprecipitated complex by the XBP1S antibody from cell lysates prepared from ATDC5 cells treated with BMP2 for 5 days (Fig.8C) . Together, these results indicate that XBP1S and Runx2 can form a protein complex in hypertrophic chondrocyte differentiation.
XBP1S enhances Runx2-induced hypertrophic chondrocyte differentiation -
Runx2 is required for hypertrophic chondrocyte differentiation and activates Collagen X expression [45] . To determine whether XBP1S also affects Runx2-dependent chondrocyte hypertrophy, ATDC5 cells were infected with adenovirus encoding XBP1S (Ad-XBP1S), Runx2 (Ad-Runx2) or combination, and RNA was extracted at day 7 for real-time PCR. As shown in Fig. 8D and E, markedly enhanced expressions of Collagen X and MMP13 in cells infected with Ad-XBP1S+Ad-Runx2 were observed compared with those in Runx2-infected cells, and XBP1S obviously increased the Collagen X and MMP13 expression induced by Runx2.The results suggested that XBP1S is a cofactor of Runx2 in regulating chondrocyte hypertrophy.
XBP1S inhibits IHH/PTHrP signaling-In chondrocyte differentiation, signaling molecules Indian hedgehog (IHH) and parathyroid hormone-related peptide (PTHrP) form a negative feedback loop that regulates the rate of chondrocyte differentiation. We then examined whether XBP1S affects this signaling pathway in chondrocyte hypertrophy. The micromass cultures of both XBP1S-overexpressing (Ad-XBP1S) and control (CTR) C3H10T1/2 cells (Fig. 9A,C) or ATDC5 (Fig. 9B,D) were cultured in the presence of BMP2 for various time points, as indicated, and the real-time PCR was performed. Compared with the control, XBP1S enhanced the expression of IHH (Fig  9A,B) , whereas it clearly suppressed the expression of PTHrP (Fig. 9C,D ) in both cell models tested. Conversely, knockdown of XBP1S using RNAi approach totally abolished IHH induction and enhanced PTHrP expression in chondrocyte differentiation of both C3H10T1/2 (Fig. 9 E, G) and ATDC5 cells (Fig. 9F,H) . Taken together, these results indicated that XBP1S also mediates IHH/PTHrP signaling, which is important for hypertrophic chondrocyte differentiation.
DISCUSSION
Growth and development of endochondral bones is controlled through the highly coordinated proliferation and differentiation of growth plate chondrocytes. Chondrocyte hypertrophy during endochondral ossification is a well-controlled process in which proliferating chondrocytes stop proliferating and differentiate into hypertrophic chondrocytes. Chondrogenesis is a process that is important for the creation of chondrocytes both during embryogenesis as well as in adult life [27, 28] . The IRE1/XBP1 branch of the UPR is known to be essential for normal development, where knock-out mice died at early embryonic stages. XBP1S is required for the terminal differentiation of B cells, hepatocytes and pancreatic β cells. It is also important for myeloma cells to survive hypoxic stress [29, 30] . UPR is primarily a response to relieve ER stress and promote survival. UPR may alter apoptosis of hypertrophic chondrocytes, which is thought to be a normal process prior to the conversion to bone. Many studies have shown that factors influencing cell fate and/or differentiation are activated in ER stress [31, 32] , but how such changes impact differentiation programs in chondrocytes is poorly understood. Therefore, to test a link between IRE1/XBP1 branch of the UPR and chondrocyte differentiation, we focused on the role of XBP1S in chondrogenesis as well as the molecular mechanism involved.
Our results showed that XBP1S protein was highly induced in the course of chondrogenesis in vitro (Fig. 1C,D) and also demonstrated prominent expression in the entire growth plate chondrocyte population in vivo (Fig. 2) . Real-time PCR for measurements of XBP1S showed that the level of XBP1S mRNA was relatively low until day 5, and at day 7 it tripled and thereafter remained at high levels during the late-differential stage (Fig. 1A, B) . The discrepancy between the protein and mRNA of XBP1S during chondrogenesis suggests that posttranscription regulations, such as translation, mRNA splice and stability, and protein degradation, might also be important in the control of XBP1S expression during chondrogenesis. Saito et al [33] reported that treatment of wild-type primary osteoblasts with BMP2 induced ER stress, leading to an increase in ATF4 protein expression levels. In mammalian cells, ER stress-inducing agents activate the IRE1α/β proteins. IRE1α is a ubiquitously expressed ER type I transmembrane protein containing both a serine/threonine kinase module and an endoribonuclease domain in its cytosolic region [34, 35] . Upon UPR activation, IRE1α executes site-specific cleavage of XBP1 mRNA to remove a 26-nucleotide intron. Religation of the 5' and 3' fragments yields a spliced XBP-1 mRNA with an altered reading frame encoding a 54-kDa basic leucine zipper transcription factor, XBP1S. XBP1S is more potent as a transcriptional activator and more stable than the 30-kDa protein translated from unprocessed XBP1 mRNA. XBP1S activates the promoters of many genes, including those coding for enzymes necessary for the degradation of improperly folded ER proteins and participates in cell proliferation and differentiation [36, 38] . In this study, we examined that ATF6 can bind ERSE of the XBP1 gene promoter and may also act through this cis-acting element to regulate promoter activity (Fig.3,4) . Here, we induced C3H10T1/2 and ATDC5 cells with BMP2 for induction of chondrocyte differentiation. The result showed that ATF6 is able to upregulate XBP1S gene expression and ATF6 is required for XBP1S expression in ATDC5 cells induced by BMP2.Then it was found that IRE1a obviously increased the XBP1S expression and splicing, ATF6 can enhance the level of IRE1a-spliced XBP1S protein in chondrogenesis. IRE1a and transcription factor ATF6 can synergistically regulate endogenous XBP1S gene expression in chondrocyte differentiation (Fig 5) .
Then we determined whether XBP1S functions as a positive regulator of hypertrophic chondrocyte differentiation, because overexpression of XBP1S enhances, whereas knockdown of XBP1S abolishes, BMP2-induced chondrocyte hypertrophy, as assayed by CollagenⅡ,Collagen X and Runx2 expression in the course of chondrocyte differentiation ( Fig.6 and 7) . Further, we sought to clarify the molecular mechanism on how to regulate chondrocyte hypertrophy by XBP1S.We found that XBP1S associates with Runx2 and enhances Runx2-induced hypertrophic chondrocyte differentiation. Runx2 (runt-related transcription factor 2) is a transcription factor that belongs to the Runx family and acquires DNA binding activity by heterodimerizing with Cbfβ [39, 40] . Runx2 has broader functions during skeletogenesis since it is, along with Runx3, an inducer of chondrocyte hypertrophy. Runx2 is a positive regulator of chondrocyte maturation [41] [42] [43] .Here our data showed that XBP1S and Runx2 can form a protein complex in chondrogenesis, then XBP1S enhances the Collagen X and MMP13 expression induced by Runx2.The results suggested that XBP1S is a cofactor of Runx2 in regulating chondrocyte hypertrophy (Fig. 8) .
It was reported that Runx2 is associated with IHH/PTHrP signaling pathway, and regulates limb growth through induction of Indian hedgehog [46] [47] [48] [49] . Next, we also determined whether XBP1S expression regulated on the IHH/PTHrP signaling pathway. All is known that multiple signaling pathways are involved in endochondral ossification in the epiphyseal growth plate [50] . Among them, PTHrP and IHH coordinately regulate the rate of chondrocyte differentiation through a negative feedback loop. Several lines of evidence indicated that PTHrP negatively regulated the endochondral bone formation. PTHrP prevents chondrocyte hypertrophy in the growth plate and maintains a pool of cells above the hypertrophic zone in a proliferative condition [51] [52] [53] . IHH is expressed at the prehypertrophic-hypertrophic boundary so that cells that escape the inhibitory action of PTHrP signaling in the growth plate express IHH, which in turn will stimulate PTHrP expression [54, 55] . It is known that the UPR element(UPRE), the ER stress response element(ERSE) and ERSEⅡ are the preferential binding site for XBP1S [56, 57] . In the IHH promoter sequence, there are two UPRE sequences(TGACGTT/G) and four ERSEⅡ sequences(CCACG/A). Besides, in the PTHrP gene promoter, there is one UPRE sequence along with five ERSEⅡ sequences. Therefore, XBP1S can regulate IHH and PTHrP transcription and expression through binding to the responsive cis-elements in their promoter region. Our studies demonstrated that altered expression of XBP1S markedly affects the levels of IHH and PTHrP. Overexpressing XBP1S enhances the expression of IHH whereas it inhibits PTHrP (Fig. 9) . Our results suggest that there might exist negative feedback regulation between XBP1S and IHH/PTHrP signaling.
In conclusion, ER stress is induced during chondrocyte differentiation and activates the IRE1a-XBP1 pathway. As summarized in Fig.  10 , we propose a model for the role of XBP1S -specifically, its expression and function -in chondrocyte differentiation. The molecular mechanism by which XBP1S acts as a novel mediator of chondrocyte hypertrophy is, at least partial, due to (1) the transactivation of XBP1 gene and increasing the expression of IRE1a-spliced XBP1S by ATF6 in chondrogenesis (Fig.4,5) ; (2) XBP1S enhances BMP2-induced chondrocyte differentiation (Fig.6,7) ; (3) the binding of XBP1S to Runx2 and acting as its cofactor for hypertrophic chondrocyte formation (Fig.8) and (4) affecting IHH/PTHrP signaling (Fig 9) , which is known to be important in controlling chondrocyte hypertrophy. Collectively, this study identifies XBP1S as a novel regulatory factor in the complex networks controlling growth plate chondrocyte prehypertrophy, hypertrophy and differentiation. Schematic structures of two XBP1-specific reporter genes. The indicated segments from the 5'-flanking region of the XBP1 gene were linked to a SV40 promoter ('SV') and a DNA segment encoding luciferase ('Luc'). Black ovals indicate the ERSE elements which are ATF6-binding elements (ABEs); numbers indicate distances in nucleotides from the first nucleotide of intron 1. C. ATF6 activates the longer pXBP1-specific reporter construct pGL3-XBP1 in both C3H10T1/2 pluripotent cells and ATDC5 chondrocytes. The reporter gene and the pCMV-gal internal control plasmid were transfected into cells together with the pcDNA3.1(−)-ATF6 expression plasmid. At 48 h after transfection, the cultures were harvested and the luciferase and β-galactosidase activities were determined; The data shown are the mean levels of luciferase activity from three independent experiments, analyzed in triplicate and normalized by β-gal activity. *P＜ 0.05. D.ATF6 activates the XBP1 promoter core sequence reporter construct pGL3-XBP1 in C3H10T1/2 cells. The same procedure as described in (C) was followed. E. Diagrams show the alterations in the ATF6-binding sites in the pGL3-XBP1 reporter gene. Mutant nucleotides are indicated by arrows. F. ATF6-dependent transactivation of the XBP1 gene was dramatically reduced when the ATF6-binding site was mutated. The wild-type or mutant reporter gene specified and the pCMV-gal internal control plasmid were transfected into ATDC5 cells together with a pcDNA3.1(−) vector (control) or a pATF6 expression plasmid, and the same procedure as described in (C) was followed.1.pGL3-XBP1(Wt); 2.pGL3-XBP1(Mut1); 3.pGL3-XBP1 (Mut2).
FIGURE LEGENDS
FIGURE 5. ATF6 increases the expression of the IRE1a-dependent XBP1S gene in chondrogenesis.
A. ATF6 activates the XBP1 promoter core sequence reporter construct pGL3-XBP1 in ATDC5 cells. The reporter gene and the pCMV-gal internal control plasmid were transfected into cells together with the pcDNA3.1(-)-ATF6 expression plasmid. At 48 h after transfection, the cultures were harvested and the luciferase and β-galactosidase activities were determined; The data shown are the mean levels of luciferase activity from three independent experiments, analyzed in triplicate and normalized by β-gal activity. *P＜ 0.05. B. ATF6 increases the level of XBP1S mRNA. ATDC5 cells infected with Ad-ATF6 or control Ad-GFP were cultured for 48 h and endogenous XBP1S gene expression was determined by real-time PCR.
The normalized values were then calibrated against the control value. The units are arbitrary, and the left bar indicates a relative level of XBP1S mRNA of 1; *P＜0.05. C. ATF6 increases the level of XBP1S expression in ATDC5 cells induced by BMP2. ATDC5 cells infected with Ad-ATF6 or siATF6 were cultured for 48 h respectively and the endogenous XBP1S protein level was determined by western blotting. siATF6 was siRNA adenovirus targeting ATF6.β-actin protein serves as an internal control; D. ATF6 increases the level of XBP1S mRNA spliced by IRE1a. ATDC5 cells infected with Ad-IRE1a, Ad-ATF6+ Ad-IRE1a or control GFP were cultured for 48 h and endogenous XBP1S gene expression was determined by real-time PCR. The normalized values were then calibrated against the control value. The units are 
